Effect of Intraoperative Paracetamol on Catheter-Related Bladder Discomfort: A Prospective, Randomized, Double-Blind Study

被引:41
|
作者
Ergenoglu, Pinar [1 ]
Akin, Sule [1 ]
Cok, Oya Yalcin [1 ]
Eker, Evren [1 ]
Kuzgunbay, Baris [2 ]
Turunc, Tahsin [2 ]
Aribogan, Anis [1 ]
机构
[1] Baskent Univ, Sch Med, Dept Anesthesiol & Reanimatol, TR-01250 Adana, Turkey
[2] Baskent Univ, Sch Med, Dept Urol, TR-01250 Adana, Turkey
关键词
catheter-related bladder discomfort; intravenous paracetamol; urologic surgery; PROSTAGLANDIN E-2 RELEASE; NERVE GROWTH-FACTOR; URINARY-BLADDER; PREVENTION; ACETAMINOPHEN; EFFICACY; TOLTERODINE; GABAPENTIN; OXYBUTYNIN;
D O I
10.1016/j.curtheres.2012.08.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND: The insertion of urinary catheters during urinary surgical interventions may lead to catheter-related bladder discomfort (CRBD) in the postoperative period. OBJECTIVE: We aimed to evaluate the effect of single-dose intravenous paracetamol on CRBD. METHODS: In this randomized, controlled, double-blind study, 64 patients (age > 18 years, American Society of Anesthesiologists Physical Status I-II) requiring urinary bladder catheterization for percutaneous nephrolithotomy were assigned to groups that received either intravenous paracetamol (15 mg/kg) (group P) or NaCl 0.9% solution (control group [group Cl) 30 minutes before the end of surgery. Patients received patient-controlled analgesia (10-mg bolus of meperidine, without infusion, 20-minute lock out) postoperatively. CRBD and pain status were assessed at 30 minutes and 1, 2, 4, 6, and 12 hours postoperatively. Postoperative meperidine requirement and patient and surgeon satisfaction were assessed. RESULTS: Group P had significantly lower CRBD scores at all time points except at 12 hours postoperatively compared with group C (P < 0.05). Total meperidine consumption was significantly higher in group C (P < 0.05). Patient and surgeon satisfaction scores were significantly higher in group P (P < 0.05). CONCLUSIONS: Intraoperative single-dose paracetamol was found to be effective in reducing the severity of CRBD and pain in urologic surgery. We suggest that it may be an efficient, reliable, easy-to-apply drug for CRBD. ClinicalTrials.gov identifier: NCT01652183. (Curr Ther Res Clin Exp. 2012;73:186-194) (C) 2012 Elsevier HS Journals, Inc.Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:186 / 194
页数:9
相关论文
共 50 条
  • [21] Dexmedetomidine for prevention of early postoperative catheter-related bladder discomfort in voluntary kidney donors: Prospective, randomized, double-blind, placebo-controlled trial
    Singh, Tapas Kumar
    Sahu, Sandeep
    Agarwal, Anil
    Gupta, Devendra
    Mishra, Prabhaker
    JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2018, 34 (02) : 211 - 215
  • [22] Prophylactic diphenhydramine attenuates postoperative catheter-related bladder discomfort in patients undergoing gynecologic laparoscopic surgery: a randomized double-blind clinical study
    Li, Yu-Yu
    Zeng, Yan-Syun
    Chen, Jen-Yin
    Wang, Kuei-Fen
    Hsing, Chung-Hsi
    Wu, Wen-Ju
    Wang, Jhi-Joung
    Feng, Ping-Hsun
    Chu, Chin-Chen
    JOURNAL OF ANESTHESIA, 2020, 34 (02) : 232 - 237
  • [23] Prophylactic diphenhydramine attenuates postoperative catheter-related bladder discomfort in patients undergoing gynecologic laparoscopic surgery: a randomized double-blind clinical study
    Yu-Yu Li
    Yan-Syun Zeng
    Jen-Yin Chen
    Kuei-Fen Wang
    Chung-Hsi Hsing
    Wen-Ju Wu
    Jhi-Joung Wang
    Ping-Hsun Feng
    Chin-Chen Chu
    Journal of Anesthesia, 2020, 34 : 232 - 237
  • [24] Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study
    Agarwal, A
    Dhiraaj, S
    Singhal, V
    Kapoor, R
    Tandon, M
    BRITISH JOURNAL OF ANAESTHESIA, 2006, 96 (03) : 377 - 380
  • [25] Intra-operative Oxycodone Reduced Postoperative Catheter-Related Bladder Discomfort Undergoing Transurethral Resection Prostate: A Prospective, Double Blind Randomized Study
    Xiong, Juncheng
    Chen, Xiang
    Weng, Chengwei
    Liu, Shuqun
    Li, Jian
    UROLOGY JOURNAL, 2019, 16 (04) : 392 - 396
  • [26] An evaluation of the efficacy of different doses of ketamine for treatment of catheter-related bladder discomfort in patients underwent urologic surgery: A prospective, randomized, placebo-controlled, double-blind study
    Safavi, Mohammadreza
    Honarmand, Azim
    Atari, Mohammadali
    Chehrodi, Shirin
    Amoushahi, Mahsa
    UROLOGY ANNALS, 2014, 6 (01) : 51 - 56
  • [27] Effects of an intraoperative intravenous Bolus Dose of Dexmedetomidine on postoperative catheter-related bladder discomfort in male patients undergoing transurethral resection of bladder tumors: a randomized, double-blind, controlled trial
    Zhang, Tianhua
    Li, Huiting
    Lin, Chunnan
    An, Rui
    Lin, Wenqian
    Tan, Hongying
    Cao, Longhui
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (03) : 465 - 474
  • [28] Comparison of intravenous tramadol and ketamine for prevention of catheter-related bladder discomfort after laparoscopic surgery: a randomized, placebo-controlled, double-blind study
    Burimsittichai, Rattanaporn
    Limraksasin, Phoonsak
    Hurst, Cameron Paul
    Charuluxananan, Somrat
    ASIAN BIOMEDICINE, 2016, 10 (03) : 253 - 260
  • [29] Effects of dezocine for the prevention of postoperative catheter-related bladder discomfort: a prospective randomized trial
    Zhang, Guang-Fen
    Guo, Jie
    Qiu, Li-Li
    Li, Shu-Ming
    Zheng, Man
    Xia, Jiang-Yan
    Yang, Jian-Jun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1281 - 1288
  • [30] Correction to: Effects of an intraoperative intravenous Bolus Dose of Dexmedetomidine on postoperative catheter-related bladder discomfort in male patients undergoing transurethral resection of bladder tumors: a randomized, double-blind, controlled trial
    Tianhua Zhang
    Huiting Li
    Chunnan Lin
    Rui An
    Wenqian Lin
    Hongying Tan
    Longhui Cao
    European Journal of Clinical Pharmacology, 2025, 81 (1) : 181 - 181